Ribosomal protein L4 pseudogene 5 (RPL4P5)

Ribosomal protein L4 pseudogene 5 (RPL4P5) is a processed pseudogene of the RPL4 gene, which encodes ribosomal protein L4, a structural component of the 60S large ribosomal subunit involved in protein synthesis[1][2]. As a pseudogene, RPL4P5 is not known to encode a functional protein and typically does not have direct biological roles; processed pseudogenes like RPL4P5 are generally considered “genomic fossils” that result from reverse transcription and reintegration of mRNA transcripts from their parent genes[1]. There is no evidence to suggest that RPL4P5 functions as a therapeutic target, biomarker, or has drug interactions. While some ribosomal protein pseudogenes (such as RPL4P4) have emerged in research as potential regulators or biomarkers in disease, including certain cancers[3], no such data currently exist for RPL4P5. Most annotations for “ribosomal protein L4 pseudogene 5” indicate it is not an active gene and should not be confused with the protein-coding RPL4 gene or other pseudogenes (such as RPL4P4) with possible regulatory functions. Additional clarification: - is_incorrect: Marked true because RPL4P5 is a pseudogene and not a therapeutic target molecule, protein, or classical biological receptor/enzyme; there is no evidence of function or targetability in the drug discovery or clinical context[1][2][5]. - This should not be conflated with “RPL4,” a bona fide ribosomal protein and essential component of the ribosome, or with “RPL4P4,” which is a different pseudogene with some recent research suggesting possible regulatory roles[3]. Notes: If your aim is to annotate targets for therapeutic or biological relevance, RPL4P5 will generally be ineligible under canonical target definitions. If you are cataloging genes and their pseudogenes for completeness, RPL4P5 can be included, but not as a therapeutic or functional target.

Other names

RPL4_3_960RPL4P5